purchased from GenScript. The cross-linker, di(N-succinimidyl) 3,3'-dithiodipropionate, was ordered from TCI EUROPE N. V. Two-stage kit, BiophenTM Anti-Xa (221005), was ordered from HYPHEN BioMed. Fresh human blood was ordered from Cambridge Bioscience Ltd. FAM and BHQ modified 22-base DNA (sequence: 5'-FAM-CCA CGC TCT GCT AAT CCT GTT A-BHQ-3'was ordered from Integrated DNA Technology.
Supplementary Methods
High Performance Liquid Chromatography (HPLC) was performed on an ÄKTA pure protein purification system equipped with a fraction collector F9-C. Reverse phase HPLC was performed with a RESOURCE RPC 1 mL column (GE Healthcare Life Sciences) and the elution buffer was: buffer A: 0.1 % TFA, H2O; buffer B: 0.1 % TFA, AcN. A HiTrap Heparin HP 5 mL column (GE Healthcare Life Sciences, elution buffer: buffer A: 10 mM PB buffer, pH 6.0; buffer B: 10 mM PB buffer, 1 M NaCl, pH 6.0.) was used to purify all products. Molecular weights were checked with Bruker MALDI-TOF, using sinapic acid as matrix. 
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